- Ticker iNav Bloomberg: IV3ELEUR
- Exchange ticker: V3EL
- Bloomberg: V3EL IM
- ISIN: IE000NRGX9M3
- MEX ID: VRAACE
- Reuters: V3EL.MI
- SEDOL: BPNZVH0
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
As at 31 paź 2025
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 989 | 974 | 31 paź 2025 |
| Median market capital | 48,4 B | 48,4 B | 31 paź 2025 |
| 16,5 x | 16,5 x | 31 paź 2025 | |
| 2,2 x | 2,2 x | 31 paź 2025 | |
| 13,1% | 13,1% | 31 paź 2025 | |
| 13,1% | 13,2% | 31 paź 2025 | |
| Portfolio turnover rate | 3,0% | — | 30 wrz 2025 |
As at 31 paź 2025
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| Wielka Brytania | Europa | 19,75% | 19,76% | -0,01% |
| Szwajcaria | Europa | 16,14% | 16,14% | 0,00% |
| Niemcy | Europa | 15,34% | 15,33% | 0,01% |
| Francja | Europa | 9,92% | 10,39% | -0,47% |
| Holandia | Europa | 9,32% | 9,33% | -0,01% |
| Szwecja | Europa | 6,91% | 6,92% | -0,01% |
| Hiszpania | Europa | 5,43% | 5,43% | 0,00% |
| Włochy | Europa | 5,31% | 5,31% | 0,00% |
| Dania | Europa | 3,87% | 3,88% | -0,01% |
| Belgia | Europa | 1,96% | 1,96% | 0,00% |
| Finlandia | Europa | 1,85% | 1,85% | 0,00% |
| Norwegia | Europa | 1,17% | 1,17% | 0,00% |
| Polska | Europa | 0,97% | 0,97% | 0,00% |
| Irlandia | Europa | 0,69% | 0,69% | 0,00% |
| Austria | Europa | 0,65% | 0,65% | 0,00% |
As at 31 paź 2025
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 3,96980% | Technology | NL | 7 272 270,10 € | 7921 |
| SAP SE | 2,53464% | Technology | DE | 4 643 197,15 € | 20 687 |
| AstraZeneca PLC | 2,33779% | Health Care | GB | 4 282 589,58 € | 30 170 |
| Nestle SA | 2,30629% | Consumer Staples | CH | 4 224 884,01 € | 50 917 |
| Novartis AG | 2,19851% | Health Care | CH | 4 027 438,86 € | 37 590 |
| Roche Holding AG | 2,15822% | Health Care | CH | 3 953 633,48 € | 14 149 |
| Siemens AG | 1,98046% | Industrials | DE | 3 628 001,25 € | 14 775 |
| Novo Nordisk A/S | 1,48116% | Health Care | DK | 2 713 339,49 € | 64 127 |
| Allianz SE | 1,47784% | Financials | DE | 2 707 255,00 € | 7775 |
| Banco Santander SA | 1,43790% | Financials | ES | 2 634 084,40 € | 298 446 |
-
Inception date
16 sie 2022
Listing date
18 sie 2022
| Date | NAV (EUR) | Market price (EUR) |
|---|---|---|
| 14 lis 2025 | 6,2681 € | 6,2800 € |
| 13 lis 2025 | 6,3486 € | 6,3610 € |
| 12 lis 2025 | 6,3864 € | 6,3980 € |
| 11 lis 2025 | 6,3419 € | 6,3600 € |
| 10 lis 2025 | 6,2542 € | 6,2700 € |
| 07 lis 2025 | 6,1674 € | 6,1760 € |
| 06 lis 2025 | 6,2057 € | 6,2140 € |
| 05 lis 2025 | 6,2443 € | 6,2580 € |
| 04 lis 2025 | 6,2332 € | 6,2370 € |
| 03 lis 2025 | 6,2485 € | 6,2590 € |
Distribution frequency
Quarterly
Historical performance 31 paź 2025
2,77%
| Type | Distribution amount (per unit) | Ex-dividend date | Registration date | Payable date |
|---|---|---|---|---|
| Income | 0,0168 € | 18 wrz 2025 | 19 wrz 2025 | 01 paź 2025 |
| Income | 0,1161 € | 19 cze 2025 | 20 cze 2025 | 02 lip 2025 |
| Income | 0,0204 € | 20 mar 2025 | 21 mar 2025 | 02 kwi 2025 |
| Income | 0,0197 € | 12 gru 2024 | 13 gru 2024 | 27 gru 2024 |
| Income | 0,0183 € | 12 wrz 2024 | 13 wrz 2024 | 25 wrz 2024 |
| Income | 0,1055 € | 13 cze 2024 | 14 cze 2024 | 26 cze 2024 |
| Income | 0,0176 € | 14 mar 2024 | 15 mar 2024 | 27 mar 2024 |
| Income | 0,0159 € | 14 gru 2023 | 15 gru 2023 | 27 gru 2023 |
| Income | 0,0169 € | 14 wrz 2023 | 15 wrz 2023 | 27 wrz 2023 |
| Income | 0,0936 € | 15 cze 2023 | 16 cze 2023 | 28 cze 2023 |
Listed currencies: EUR, GBP
Base currency: EUR
Exchanges: NYSE Euronext - Amsterdam, London Stock Exchange, Deutsche Boerse, Borsa Italiana S.p.A.